| Viyash Scientific Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 512529 |
NSE Symbol : VIYASH |
P/E(TTM) : 117.12 |
|
ISIN Demat : INE807F01027 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.93 |
|
Book Value(₹) : 70.11 |
Market Cap(₹Cr) : 9,986.07 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 353.69 | 372.49 | 341.64 | 339.75 | 328.18 | 42.33 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 353.69 | 372.49 | 341.64 | 339.75 | 328.18 | 42.33 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 14.59 | 19.75 | 16.29 | 17.32 | 12.90 | 12.27 |
| Total Income | 368.28 | 392.24 | 357.93 | 357.07 | 341.08 | 54.60 |
| Total Expenditure | 306.54 | 309.80 | 312.56 | 289.40 | 279.98 | 45.40 |
| PBIDT | 61.74 | 82.44 | 45.37 | 67.67 | 61.10 | 9.20 |
| Interest | 1.44 | 2.53 | 3.56 | 4.10 | 6.02 | 0.99 |
| PBDT | 60.30 | 79.91 | 41.81 | 63.57 | 55.08 | 8.21 |
| Depreciation | 32.41 | 31.16 | 31.20 | 30.90 | 30.89 | 2.30 |
| Tax | 4.62 | 14.98 | -25.69 | 14.71 | 11.21 | 1.11 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.35 | -2.04 | 36.38 | -4.88 | -4.32 | 0.57 |
| Reported Profit After Tax | 20.92 | 35.81 | -0.08 | 22.84 | 17.30 | 4.23 |
| Extra-ordinary Items | 0.00 | 0.00 | -4.88 | -0.93 | -0.67 | -0.18 |
| Adjusted Profit After Extra-ordinary item | 20.92 | 35.81 | 4.80 | 23.77 | 17.97 | 4.41 |
| EPS (Unit Curr.) | 0.48 | 0.82 | 0.00 | 0.53 | 0.14 | 0.17 |
| EPS (Adj) (Unit Curr.) | 0.48 | 0.82 | 0.00 | 0.53 | 0.14 | 0.17 |
| Calculated EPS (Unit Curr.) | 0.48 | 0.82 | 0.00 | 0.91 | 0.69 | 0.17 |
| Calculated EPS (Adj) (Unit Curr.) | 0.48 | 0.82 | 0.00 | 0.91 | 0.69 | 0.17 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.92 | 3.28 | -0.01 | 3.63 | 2.76 | 0.68 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.92 | 3.28 | -0.01 | 3.63 | 2.76 | 0.68 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 87.37 | 87.37 | 87.22 | 50.33 | 50.07 | 50.06 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 17.46 | 22.13 | 13.28 | 19.92 | 18.62 | 21.73 |
| PBDTM(%) | 17.05 | 21.45 | 12.24 | 18.71 | 16.78 | 19.40 |
| PATM(%) | 5.91 | 9.61 | -0.02 | 6.72 | 5.27 | 9.99 |
